Free Trial

Rep. Julia Letlow Purchases Shares of Leonardo DRS, Inc. (NASDAQ:DRS)

Leonardo DRS logo with Aerospace background
Image from MarketBeat Media, LLC.

Key Points

  • Representative Julia Letlow (R‑LA) disclosed a purchase of between $1,001 and $15,000 in Leonardo DRS (NASDAQ:DRS) shares on Feb. 2, reported in a filing dated March 12 through her Merrill Lynch account.
  • Leonardo DRS recently posted $0.42 EPS on $1.06 billion in quarterly revenue, has a $11.93 billion market cap and a P/E of 43.5, and pays a $0.09 quarterly dividend (≈0.8% yield) with a 52‑week range of $28.17–$49.31.
  • Company insiders have been net sellers (about 40,218 shares in the last 90 days, including the CFO selling 16,330 shares), while analysts' consensus is a "Moderate Buy" with a $51 average price target.
  • Five stocks we like better than Leonardo DRS.

Representative Julia Letlow (Republican-Louisiana) recently bought shares of Leonardo DRS, Inc. NASDAQ: DRS. In a filing disclosed on March 12th, the Representative disclosed that they had bought between $1,001 and $15,000 in Leonardo DRS stock on February 2nd. The trade occurred in the Representative's "MERRILL LYNCH INVESTMENT ACCOUNT #025" account.

Representative Julia Letlow also recently made the following trade(s):

  • Sold $1,001 - $15,000 in shares of HF Sinclair NYSE: DINO on 2/20/2026.
  • Sold $1,001 - $15,000 in shares of BXP NYSE: BXP on 2/20/2026.
  • Purchased $1,001 - $15,000 in shares of Travelers Companies NYSE: TRV on 2/20/2026.
  • Sold $1,001 - $15,000 in shares of Expand Energy NASDAQ: EXE on 2/17/2026.
  • Sold $1,001 - $15,000 in shares of Public Service Enterprise Group NYSE: PEG on 2/17/2026.
  • Purchased $1,001 - $15,000 in shares of Vistra NYSE: VST on 2/17/2026.
  • Sold $1,001 - $15,000 in shares of AT&T NYSE: T on 2/12/2026.
  • Purchased $1,001 - $15,000 in shares of Extra Space Storage NYSE: EXR on 2/12/2026.
  • Sold $1,001 - $15,000 in shares of Icon NASDAQ: ICLR on 2/12/2026.
  • Purchased $1,001 - $15,000 in shares of Regeneron Pharmaceuticals NASDAQ: REGN on 2/12/2026.

Leonardo DRS Price Performance

NASDAQ:DRS opened at $44.84 on Friday. The company has a 50-day moving average of $42.59 and a 200-day moving average of $39.61. The company has a market capitalization of $11.93 billion, a price-to-earnings ratio of 43.53, a PEG ratio of 3.31 and a beta of 0.41. Leonardo DRS, Inc. has a 52 week low of $28.17 and a 52 week high of $49.31. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.60 and a current ratio of 1.89.

Leonardo DRS (NASDAQ:DRS - Get Free Report) last posted its earnings results on Sunday, February 15th. The company reported $0.42 earnings per share for the quarter. Leonardo DRS had a net margin of 7.62% and a return on equity of 11.68%. The business had revenue of $1.06 billion for the quarter. As a group, equities research analysts anticipate that Leonardo DRS, Inc. will post 1.04 earnings per share for the current fiscal year.

Leonardo DRS Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 24th. Stockholders of record on Tuesday, March 10th were paid a $0.09 dividend. The ex-dividend date was Tuesday, March 10th. This represents a $0.36 dividend on an annualized basis and a dividend yield of 0.8%. Leonardo DRS's dividend payout ratio is currently 34.95%.

Institutional Trading of Leonardo DRS

Several hedge funds have recently modified their holdings of the company. First Trust Advisors LP boosted its holdings in shares of Leonardo DRS by 116.8% in the 3rd quarter. First Trust Advisors LP now owns 3,661,214 shares of the company's stock worth $166,219,000 after acquiring an additional 1,972,596 shares in the last quarter. Norges Bank acquired a new stake in Leonardo DRS during the 4th quarter valued at $37,481,000. Millennium Management LLC raised its position in Leonardo DRS by 152.1% in the 3rd quarter. Millennium Management LLC now owns 1,776,185 shares of the company's stock valued at $80,639,000 after purchasing an additional 1,071,708 shares during the last quarter. AQR Capital Management LLC boosted its stake in Leonardo DRS by 528.6% in the third quarter. AQR Capital Management LLC now owns 1,273,444 shares of the company's stock worth $56,000,000 after purchasing an additional 1,070,870 shares in the last quarter. Finally, Invesco Ltd. grew its holdings in shares of Leonardo DRS by 30.1% during the second quarter. Invesco Ltd. now owns 3,768,160 shares of the company's stock worth $175,144,000 after purchasing an additional 870,772 shares during the last quarter. Institutional investors and hedge funds own 18.76% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on DRS shares. Truist Financial set a $59.00 price objective on Leonardo DRS in a report on Wednesday, February 25th. Morgan Stanley set a $47.00 target price on Leonardo DRS in a research report on Wednesday, February 25th. Weiss Ratings raised Leonardo DRS from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Friday, March 20th. Bank of America upped their price target on Leonardo DRS from $50.00 to $55.00 and gave the company a "buy" rating in a research report on Wednesday. Finally, Wall Street Zen lowered Leonardo DRS from a "buy" rating to a "hold" rating in a research note on Saturday, February 28th. Six investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $51.00.

Read Our Latest Stock Analysis on DRS

Insider Activity

In related news, CFO Michael Dippold sold 16,330 shares of Leonardo DRS stock in a transaction dated Monday, March 16th. The stock was sold at an average price of $45.27, for a total value of $739,259.10. Following the completion of the transaction, the chief financial officer directly owned 26,622 shares of the company's stock, valued at $1,205,177.94. The trade was a 38.02% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Pamela Morrow sold 12,000 shares of the company's stock in a transaction dated Tuesday, March 3rd. The stock was sold at an average price of $45.20, for a total transaction of $542,400.00. Following the transaction, the senior vice president owned 6,494 shares in the company, valued at approximately $293,528.80. This trade represents a 64.89% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 40,218 shares of company stock worth $1,719,136. 0.34% of the stock is owned by corporate insiders.

About Representative Letlow

Julia Letlow (Republican Party) is a member of the U.S. House, representing Louisiana's 5th Congressional District. She assumed office on April 14, 2021. Her current term ends on January 3, 2027. Letlow (Republican Party) is running for re-election to the U.S. House to represent Louisiana's 5th Congressional District. She declared candidacy for the primary scheduled on November 3, 2026. Julia Letlow earned a doctorate. Letlow's career experience includes working as a senior administrator with the University of Louisiana at Monroe.

About Leonardo DRS

(Get Free Report)

Leonardo DRS is a U.S.-based defense technology company and wholly owned subsidiary of Italy's Leonardo S.p.A. The firm specializes in developing and integrating mission-critical systems for military and government customers, with a primary focus on command, control, communications, computers, intelligence, surveillance and reconnaissance (C4ISR). Its core offerings encompass advanced sensors, targeting systems, radars and electronic warfare solutions designed to enhance situational awareness and operational effectiveness across land, sea and air domains.

The company's portfolio includes naval combat management systems, unmanned vehicle sensors, power generation and distribution equipment, and training and simulation solutions.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Leonardo DRS Right Now?

Before you consider Leonardo DRS, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Leonardo DRS wasn't on the list.

While Leonardo DRS currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines